Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3NY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,073
Award facts
- Contract value 100% obligated
- $22,073.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $22,073.28 to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 mg/24 ml vials on January 20, 2026, with completion scheduled for February 10, 2026. This firm fixed-price, non-set-aside contract will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00 and extends through December 31, 2031, serving as a comprehensive vehicle for pharmaceutical and medical supply distribution to support military healthcare programs globally.
AmerisourceBergen, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor and critical federal vendor specializing in supplying brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. The company's extensive portfolio of federal contract awards with DLA demonstrates its capability to compete successfully in open procurement and efficiently fulfill government medical supply requirements. This delivery order for OPDIVO, an oncology therapeutic, reflects the company's established role in supporting the Defense Health Agency and other federal healthcare systems with essential pharmaceutical commodities.
Quick answers
Who was awarded contract SPE2DR26FG3NY?
SPE2DR26FG3NY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FG3NY worth?
The government has obligated $22,073 on SPE2DR26FG3NY.
Is contract SPE2DR26FG3NY an order under another contract?
Yes. SPE2DR26FG3NY is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3NY competed?
The extent of competition for SPE2DR26FG3NY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award